NCT00003007View on ClinicalTrials.gov

Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Timeline

Start Date

July 31, 1996

Study Completion Date

January 31, 2004

Conditions

Multiple Myeloma and Plasma Cell Neoplasm

Interventions

BIOLOGICAL

recombinant interferon alfa

BIOLOGICAL

sargramostim

DRUG

cyclophosphamide

DRUG

dexamethasone

DRUG

melphalan

PROCEDURE

peripheral blood stem cell transplantation

Trial Locations (4)

38103

William F. Bowld Hospital, Memphis

38104

Methodist Healthcare - Hospital of Memphis, Memphis

38146

Baptist Memorial Hospital, Memphis

38163

University of Tennessee, Memphis, Memphis

All Listed Sponsors

lead

University of Tennessee

OTHER

NCT00003007 - Interferon Alfa Following Chemotherapy and Peripheral Stem Cell Transplantation in Treating Patients With Stage III or Stage IV Multiple Myeloma | Biotech Hunter | Biotech Hunter